Healthcare -
Biotechnology - NASDAQ - US
$ 8.92
-1.76 %
$ 522 M
Market Cap
-3.21
P/E
CGEM - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss CGEM - Cullinan Oncology, Inc.
-129 K
LAST VALUE
60.77%
2 YEAR CAGR
-164.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR